No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
WGSWW GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)
- 0.155
- +0.005+3.30%
Close Dec 24 13:00 ET
0.158High0.140Low
0.158High0.140Low23.40KVolume0.156Open0.150Pre Close3.55KTurnover0.00%Turnover Ratio--P/E (Static)0Shares0.31552wk High--P/B0Float Cap0.00252wk Low--Dividend TTM0Shs Float4.350Historical High--Div YieldTTM11.67%Amplitude0.002Historical Low0.151Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
News
Form 144 | GeneDx Holdings(WGS.US) Officer Proposes to Sell 3.29 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 19, $GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$、$GeneDx Holdings(WGS.US)$ Officer Ryan Jason intends to sell 47,000 shares of its common stock on Nov 19,
Form 144 | GeneDx Holdings(WGS.US) 10% Stockholder Proposes to Sell 82.75 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 31, $GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$、$GeneDx Holdings(WGS.US)$ 10% Stockholder ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI intends to sell 1.01
10-Q: Q3 2024 Earnings Report
8-K: GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights
10-Q: Q2 2024 Earnings Report
8-K: GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights